Stock listing

NASDAQ:TPTX Turning Point Therapeutics Inc Stock

Follow Turning Point Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:TPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TPTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Turning Point Therapeutics Inc on 6ix

Calls
4 calls with a replay · 4 with a transcript · latest Aug 9, 2021
Decks
8 decks · latest May 10, 2022

Events

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2022)Investor deck53 slidesMay 10, 2022
Technical Presentation (April 2022)Technical15 slidesApr 13, 2022
Investor Presentation (October 2021)Investor deck46 slidesOct 8, 2021
AACR-NCI-EORTC Investor Meeting 2021Conference29 slidesOct 7, 2021
Investor Presentation (January 2021)Investor deck33 slidesJan 11, 2021
Investor Presentation (October 2020)Investor deck30 slidesOct 26, 2020
Technical Presentation (August 2020)Technical17 slidesAug 19, 2020
38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference21 slidesJan 13, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carol Giltner Gallagher
Other companies: PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past)
Director · Jul 24, 2019 – Aug 17, 2022 · Past
Garry A Nicholson
Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past)
Director · Jun 2, 2021 – Aug 17, 2022 · Past
Simeon George
Other companies: ADARx Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2026); Design Therapeutics, Inc. (Director · Since at least Jun 15, 2022); CRISPR Therapeutics AG (Director · Since at least Jun 9, 2022); Nkarta, Inc. (Member of Board of Directors · Since at least Apr 28, 2022)
Director · Aug 17, 2022 – Aug 17, 2022 · Past
Mark J Alles
Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past); Celgene Corporation (CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past)
Director · May 24, 2021 – Aug 17, 2022 · Past
Mohammad Hirmand
Other companies: Whitehawk Therapeutics, Inc. (Director · Since at least Mar 27, 2023); Medivation Inc (Interim Chief Medical Officer · Sep 29, 2015 – Sep 28, 2016 · Past)
EVP and Chief Medical Officer · Dec 2, 2019 – Aug 17, 2022 · Past
Steve M Sabus
Other companies: Syndax Pharmaceuticals, Inc. (Chief Commercial Officer · Dec 5, 2022 – Dec 5, 2022 · Past)
SVP & Chief Commercial Officer · May 31, 2022 – Aug 17, 2022 · Past
Annette NorthEVP & General Counsel · Apr 16, 2019 – Feb 9, 2022 · Past
Brian SunSVP & General Counsel · Apr 11, 2022 – Aug 17, 2022 · Past
Paolo TombesiEVP & Chief Financial Officer · Jul 27, 2022 – Aug 17, 2022 · Past
Siegfried ReichEVP & Chief Scientific Officer · Feb 8, 2021 – Feb 9, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Turning Point Therapeutics Inc.